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Immunological mechanisms in the pathogenesis of vinyl chloride disease A MILFORD WARD, SOPSAMORN UDNOON, J WATKINS, ANNE E WALKER, C S DARKE British Medical Journal, 1976, 1, [936] [937] [938] Summary Vinyl chloride (VC) disease is a multisystem disorder incorporating Raynaud's phenomenon, acro-osteolysis, thrombocytopenia, portal fibrosis, and hepatic and pulmonary dysfunction. Immunological and immunochemical investigations showed the presence of circulating immune complexes in 19 out of 28 patients with the disease and in a further two out of 30 workers exposed to VC. The immunological data were reviewed in relation to the clinical picture of the disease and to the available evidence on the metabolism of VC. The results suggest that VC disease is an immune complex disorder and that the immune response is initiated by the adsorption of VC or a metabolite on to tissue or plasma protein.
Introduction
Vinyl chloride (VC) is known to be oncogenic,' 2 but hepatic angiosarcoma may not be the most serious of its medical hazards. Acro-osteolysis was first described in 1966 in workers employed in the polymerisation of VC,3 and since then other cases have been described.4 In all these reports the affected workers helped in cleaning the autoclaves after the polymerisation process. Stewart et al, 6 however, reported a case in a worker who had never done this job. Their report widened the possible exposure to toxic levels of VC to other workers in the industry. The descriptions of acro-osteolysis do not describe adequately the full extent of the disorder as it may affect VC workers. The syndrome for which Lange et al7 suggested the name vinyl chloride disease includes sclerotic changes in the skin, osteolysis, circulatory disturbances, thrombocytopenia, portal fibrosis, and impaired hepatic and pulmonary function.
Despite considerable effort in many countries little is understood about the aetiology and pathogenesis of VC disease. We therefore outline the immunological investigations performed on 58 workers from a VC polymerisation plant. The results explain the pathogenetic mechanisms of the disease and allow some conclusions to be drawn about its aetiology.
Patients
The 58 patients were referred to a hospital clinic from a single VC polymerisation plant. They represented 18%z, of the past and present work force (320). Referrals of those still working at the plant were from either the factory medical officer or local general practitioners; ex-employees were referred after investigations made by the Employment Medical Advisory Service. For the purposes of the study the patients were divided into four clinical groups.
Group 1 (9 patients)-These patients were disabled by pain in limbs and hands and by dyspnoea. All had symptomatic Raynaud's phenomenon, which in five was clinically demonstrable; the others had severely cold hands. Four had scleroedema of the hands or face, four a mild clawing deformity of the hands, and two mild radiological evidence of acro-osteolysis. 
Results
The major abnormalities observed were a polyclonal increase in one of the immunoglobulin classes, usually IgG; the presence of mixed cryoglobulins, including IgG, C3, and fibrinogen; and in-vivo conversion of both C4 and C3. Autoantibody screening (table II) showed no abnormalities except for a high incidence of antinuclear antibodies in group 1. These were all of low titre (IgG 1/20-1/50) and probably resulted from tissue damage rather than an autoaggressive disease process. The only other observation of note was the presence of thyroid autoantibodies in three patients in group 2.
There was evidence of a reduction in the T cell population with a slight increase in B cells; this was most pronounced in group 1 but was also evident in group 2 and to a less extent in group 3. In-vitro stimulation showed few abnormalities except for an apparently increased frequency of reduced or absent responses to PPD. PHA transformation studies showed minor degrees of suppression, and inhibition by plasma was not seen.
Direct immunofluorescence studies of biopsy specimens of skin (10 cases), muscle (one case), and lung (one case) showed aggregates of IgG, C4, C3, and fibrinogen/fibrin in the lumen of vessels and adherent to the vascular endothelium. IgG., C4, C3, and fibrin were also detected in the media and subintimal regions of small and medium-sized arterioles.
Discussion
The major immunological features of VC disease in this series are hyperimnmunoglobulinaemia, cryoglobulinaemia and cryofibrinogenaemia, and in-vivo conversion of complement involving the classic activation pathway via C4 and C3. There was additional evidence of a cellular disturbance in the form of a reduced T cell population and a modest increase in B cells. The presence of non-organ-specific antitissue antibodies in those most severely affected clinically may have related to tissue damage rather than to a pathogenetic mechanism.
Immunofluorescence studies of the biopsy material confirmed the immunochemical evidence of circulating immune complexes with the identification of immunoglobulin, complement, and fibrin/fibrinogen in the lumen of vessels, adherent to endothelium, and in the vessel wall. An immune complex or cryoglobulinaemic vasculitis would be consistent with the findings of a perivascular inflammatory infiltrate as described by Markowitz et al,5 although the severe narrowing of dermal vessels with subintimal fibrosis described by Harris and Adams4 could be construed as an end-stage phenomenon of a similar process. Both histological features were present in this series, although the subintimal proliferation was seen only in the cases of longest duration. The tendency towards thrombocytopenia noted in many patients could be construed as confirmatory of an immune complex disorder with complement activation.'2 The persistence of disease activity as evidenced by the presence of cryoprecipitate and conversion of complement in workers who had been removed from exposure to VC for more than six months is in accord with the observations of Veltman et al."3
Despite these pronounced abnormalities a search of published work on VC disease failed to disclose any similar investigation, most reports having concentrated on the hepatotoxic effects of VC and its oncogenic properties. Danishevsky and Egorev'4 showed that tissue damage from VC could produce allergenic substances. Hervieux and Tessier'5 had shown that a chemical dermatitis could be induced among workers in the industry. One patient in group 1 complained of skin irritation a year before, with evidence of Raynaud's phenomenon and dyspnoea, and gave a positive reaction to a patch test with polyvinyl chloride (PVC) powder. One other patient (group 3) had also complained of severe generalised pruritus.
In a detailed study of 13 patients employed in PVC production with circulatory disturbances, thrombocytopenia, splenomegaly, and hepatic malfunction, Lange et al7 concluded that there was no evidence for an autoaggressive disorder. A more recent report'3 detailed the investigation of 70 patients from a work force of 128 at a single plant, the findings of which did not change the earlier conclusions. These workers did make the point, however, that although skin and bone changes may disappear when the patient is removed from contact with VC, the thrombocytopenia may persist for 12-18 months after exposure.
In a study of 36 workers exposed to VC who were shown to have leucopenia, thrombocytopenia, and splenomegaly, Suciu et a!"6 showed an increase in the y-globulin in 11. Although they found only a 6'o and 2 9",, incidence of clinical Raynaud's phenomenon in two series of VC workers, they noted that the phenomenon cleared spontaneously on removal from exposure and that the different incidence figures were associated with a 22-fold decrease in VC levels. They also quoted a much higher (66",, and 55". respectively) incidence of vasospastic changes in discussing the significance of the splenogmealy, they suggested that VC acted as an irritant in the reticuloendothelial system to produce a reactive splenic enlargement. Marsteller et al," 7 in an extensive investigation of 50 VC workers, introduced some immunological tests into the initial protocol but abandoned them when they failed to give positive results. No comment was made on the presence or absence of hypergammaglobulinaemia. These workers also suggested the possibility of reticuloendothelial stimulation as a cause of the splenomegaly and the hepatic littoral cell hyperplasia, although they regarded the latter as a possible pathogenetic factor in the development of hepatic angiosarcoma. 23 resulting in further activation of the complement pathway and thus reinforcing the terminal recycling phenomenon.
The frequency with which abnormalities were detected in exposed workers in this series, especially in those groups (2 and 3) in which there were few or no overt clinical signs, suggests that the disease process may be more common than is generally supposed. Further studies are in progress to investigate the total exposed population at the factory and to study populations from other related industrial plants.
